Drug Shortage Report for METHOTREXATE INJECTION USP

Last updated on 2017-10-18 History
Report ID 2612
Drug Identification Number 02398427
Brand name METHOTREXATE INJECTION USP
Common or Proper name METHOTREXATE
Company Name SANDOZ CANADA INCORPORATED
Market Status CANCELLED POST MARKET
Active Ingredient(s) METHOTREXATE
Strength(s) 25MG
Dosage form(s) SOLUTION
Route of administration INTRA-ARTERIAL INTRAMUSCULAR INTRAVENOUS
Packaging size 2mL fiole/vial
ATC code L01BA
ATC description ANTIMETABOLITES
Reason for shortage Other (Please describe in comments)
Anticipated start date 2017-03-14
Actual start date
Estimated end date 2017-08-28
Actual end date 2017-08-25
Shortage status Resolved
Updated date 2017-10-18
Company comments Available in 20mL format
Health Canada comments
Tier 3 Status No
Contact Address 110 RUE DE LAUZON
BOUCHERVILLE, QUEBEC
CANADA J4B 1E6
Company contact information 1 800-361-3062

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v16 2017-10-18 French Compare
v15 2017-10-18 English Compare
v14 2017-07-06 French Compare
v13 2017-07-06 English Compare
v12 2017-06-06 French Compare
v11 2017-06-06 English Compare
v10 2017-03-28 French Compare
v9 2017-03-28 English Compare
v8 2017-03-21 French Compare
v7 2017-03-21 English Compare
v6 2017-03-15 English Compare
v5 2017-03-14 French Compare
v4 2017-03-14 English Compare
v3 2017-03-14 French Compare
v2 2017-03-14 English Compare
v1 2017-03-14 English Compare

Showing 1 to 16 of 16